BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261029T170000
DTEND;TZID=Europe/Paris:20261029T180000
DTSTAMP:20261008T162216Z
CREATED:20260714T120304Z
LAST-MODIFIED:20261008T162216Z
UID:14577-1793293200-1793296800@paradigms.foundation
SUMMARY:Live Webinar on how healthcare system classification impacts treatment choice in multiple sclerosis
DESCRIPTION:Healthcare systems play a fundamental role in determining how people living with Multiple Sclerosis (MS) access diagnosis\, treatment and long-term specialist care. While scientific advances continue to expand therapeutic options\, differences in healthcare organisation\, reimbursement policies\, drug availability and clinical pathways create substantial variation in patient care across countries. \n\n\n\nIn this expert panel discussion\, Thomas Berger will moderate a conversation with leading European neurologists and Paradigms members to explore how healthcare systems influence the delivery of optimal MS care. Through country-specific perspectives and interactive discussion\, the panel examines practical challenges\, identifies successful approaches\, and considers how healthcare systems can evolve to improve access to high-quality care while making efficient use of available resources. \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLearning Objectives\n\n\n\nFollowing this webinar\, participants should be better able to: \n\n\n\n\nRecognize how differences in healthcare systems\, national guidelines and reimbursement policies can influence MS treatment choices and access to care.\n\n\n\nDiscuss the importance of balancing treatment costs with the broader clinical and societal burden of MS when considering healthcare resource allocation.\n\n\n\nExplore the role of neurologists\, multidisciplinary teams\, registries and real-world data in supporting evidence-based and integrated MS care.\n\n\n\nIdentify key considerations for sustainable access to high-quality MS treatments\, including treatment availability\, quality and continuity of supply.\n\n\n\nConsider opportunities to strengthen patient involvement in treatment decisions\, care delivery and data generation.\n\n\n\n\nWho should attend?\n\n\n\nThis webinar is intended for: \n\n\n\n\nClinically active neurologists\n\n\n\nMultiple Sclerosis specialists\n\n\n\nNeurology residents and trainees\n\n\n\nMS nurses and other healthcare professionals involved in multidisciplinary MS care\n\n\n\n\nThe webinar will be submitted for accreditation to the relevant Belgian authorities. \n\n\n\nRecording\n\n\n\nThe webinar recording is expected to be published on the ParadigMS educational platform following the live session. Access will be restricted to healthcare professionals. \n\n\n\nRegistration\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLanguage\n\n\n\nThe session will be held in English with  \n\n\n\nFind out more about the speakers: \n\n\n\nSpeakers\n\n\n\n\nThomas Berger (AT) (Moderator)\n\n\n\nMelinda Magyari (DK)\n\n\n\nNikolaos Grigoriadis (GR)\n\n\n\nJelena Drulovic (RS)\n\n\n\nMagd Zakaria (EG)\n\n\n\nTjalf Ziemssen (DE)\n\n\n\n\n\n\n\n\n\nThomas Berger\n\n\n\n\nProfessor of Neurology and Chair of the Dept. of Neurology at the Medical University of Vienna  \n\n\n\n\n\n\n\n\n\n\n\n\nMagd Zakaria\n\n\n\n\nHead of the Multiple Sclerosis Unit at the Ain Shams Specialized University Hospital  \n\n\n\n\n\n\n\n\n\n\n\n\nMelinda Magyari\n\n\n\n\nDirector of the Danish Multiple Sclerosis Registry \n\n\n\n\n\n\n\n\nTjalf Ziemssen\n\n\n\n\nProfessor of Clinical Neuroscience at University Clinic Carl-Gustav Carus in Dresden \n\n\n\n\n\n\n\n\n\n\n\n\nNikolaos Grigoriadis\n\n\n\n\nProfessor of Neurology at the Aristotle University of Thessaloniki \n\n\n\n\n\n\n\n\n\n\n\n\nJelena Drulovic\n\n\n\n\nProfessor of Neurology at the Faculty of Medicine\, University of Belgrade \n\n\n\n\n\n\n\nFunding \n\n\n\nThis webinar was organized with the financial support of Sandoz. \n\n\n\nSandoz has not been involved in the elaboration of the presentations.
URL:https://paradigms.foundation/event/how-healthcare-system-classification-impacts-treatment-choice-in-multiple-sclerosis/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/07/PMS-PROD-webinar-261029-banner-1080x655px.jpg
END:VEVENT
END:VCALENDAR